MD Anderson Cancer Center 13th Update on the Management of Genitourinary Malignancies Conference
The MD Anderson Cancer Center (MDACC) 13th Update on the [...]
Potential of microRNAs as biomarkers for renal cell carcinoma
A recent review of the knowledge about the potential clinical [...]
Microwave ablation for small kidney tumours
A recent retrospective review of the literature and clinical trials, [...]
Cabozantinib for the treatment of non-clear cell kidney cancer
A recent study published in the European Journal of Cancer shows [...]
Safety and tolerability of atezolizumab plus bevacizumab combination for untreated metastatic kidney cancer
The combined safety results of two studies with the atezolizumab [...]
ESMO 2018: Cabozantinib in combination with atezolizumab in metastatic kidney cancer
The following video interview from Practice Update discusses the promising results [...]
Tivozanib expected to be included in European clinical practice guidelines for advanced kidney cancer
Tivozanib is expected to be included as a first-line treatment [...]
A type of white blood cell as a potential biomarker to predict response to TKIs and overall survival
A study investigating the prognostic and predictive value of a [...]
Almost half of all kidney cancer patients initially misdiagnosed
The results of the annual Kidney Cancer UK patient survey [...]
ESMO 2018: Interviews with the kidney cancer experts
The following video interviews with kidney cancer experts from the [...]
